市场调查报告书
商品编码
1291352
一次性使用生物反应器市场:2023-2028年全球行业趋势、份额、规模、增长、机会和预测Single-Use Bioreactors Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
全球一次性生物反应器市场规模在2022年达到29亿美元。展望未来,IMARC集团预计,到2028年,市场规模将达到72亿美元,在2023-2028年期间呈现15.3%的增长率(CAGR)。
一次性使用生物反应器(SUB),也被称为一次性生物反应器,依靠一个一次性袋子,而不是使用不锈钢或玻璃制成的培养容器。它使用和安装灵活方便,所需的公用设施也较少,包括蒸汽和水。除此之外,它还能降低劳动成本,将交叉污染的风险降到最低,并消除了清洁过程和验证问题。因此,它在全世界的合同研究组织(CRO)和合同制造组织(CMO)中得到了广泛的应用。
一次性使用生物反应器被用于制药行业的培养基和缓冲液制备、细胞采集、过滤、纯化和病毒灭活。它们也被用于学术和商业规模的实验室,用于药物发现、生物燃料制造以及疫苗和抗体的开发。这与蓬勃发展的生物制药业相结合,是推动市场增长的关键因素之一。此外,对传统生物反应器进行高压灭菌可能成为一个漫长、昂贵和不稳定的制药过程。然而,SUBs利用预消毒的生物工艺袋,因此减少了额外的成本和消毒时间。除此之外,由于它们比传统的生物反应器有更少的活动部件,SUBs的维护成本更低。除此之外,与不锈钢设备相比,SUBs对环境的总体影响较小。这一点,再加上世界各地越来越多的临床试验,正在催化它们在全球的需求。此外,领先的企业越来越重视产品创新和并购(M&A),以扩大他们的客户群和增加他们的地理分布。这一点,加上对一次性使用技术(SUT)的不断采用,正在增强整体销售和盈利能力。
The global single-use bioreactors market size reached US$ 2.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.2 Billion by 2028, exhibiting a growth rate (CAGR) of 15.3% during 2023-2028.
A single-use bioreactor (SUB), also known as a disposable bioreactor, relies on a disposable bag instead of a culture vessel made using stainless steel or glass. It is flexible and easy to use and install, and requires fewer utility requirements, including steam and water. Besides this, it reduces labor costs, minimizes the risk of cross-contamination, and eliminates the cleaning process and validation issue. As a result, it finds extensive applications in contract research organizations (CROs) and contract manufacturing organizations (CMOs) worldwide.
SUBs are employed in the pharmaceutical industry for media and buffer preparation, cell harvesting, filtration, purification, and virus inactivation. They are also used in academic and commercial-scale laboratories for drug discovery, biofuel manufacturing, and the development of vaccines and antibodies. This, in confluence with the burgeoning biopharmaceutical industry, represents one of the key factors impelling the growth of the market. Moreover, autoclaving a conventional bioreactor can become a lengthy, costly, and inconsistent pharmaceutical manufacturing process. However, SUBs utilize presterilized bioprocess bags and consequently reduce the additional costs and time of sterilization. Besides this, as they have fewer moving parts than conventional bioreactors, SUBs are less expensive to maintain. Apart from this, SUBs have a lower overall impact on the environment compared to stainless steel equipment. This, coupled with the growing number of clinical trials around the world, is catalyzing their demand across the globe. Furthermore, leading players are increasingly focusing on product innovations and mergers and acquisitions (M&A) to expand their customer base and increase their geographical presence. This, along with the rising adoption of single-use technology (SUT), is augmenting the overall sales and profitability.
IMARC Group provides an analysis of the key trends in each sub-segment of the global single-use bioreactors market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, type, cell type, molecule type and end user.
Single-use Bioreactor Systems
Media Bags
Filtration Assemblies
Others
Stirred-tank Bioreactors
Wave-induced Bioreactors
Bubble-column Bioreactors
Others
Mammalian Cell
Bacteria
Yeast
Others
Vaccines
Monoclonal Antibodies
Stem Cells
Recombinant Proteins
Others
Pharmaceutical and Biopharmaceutical Companies
Contract Research Organizations
Academic and Research Institutes
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being ABEC Inc., Cellexus, Celltainer Biotech B.V., CESCO Bioengineering Co. Ltd., Distek Inc., Eppendorf SE, General Electric Company, Getinge AB, Merck KGaA, Pall Corporation (Danaher Corporation), PBS Biotech Inc., Sartorius AG and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report
1. What was the size of the global single-use bioreactors market in 2022?
2. What is the expected growth rate of the global single-use bioreactors market during 2023-2028?
3. What are the key factors driving the global single-use bioreactors market?
4. What has been the impact of COVID-19 on the global single-use bioreactors market?
5. What is the breakup of the global single-use bioreactors market based on the product type?
6. What is the breakup of the global single-use bioreactors market based on the type?
7. What is the breakup of the global single-use bioreactors market based on the cell type?
8. What is the breakup of the global single-use bioreactors market based on the molecule type?
9. What are the key regions in the global single-use bioreactors market?
10. Who are the key players/companies in the global single-use bioreactors market?
Figure 98 Middle East and Africa: Single-use Bioreactor Market: Sales Value (in Million US$), 2017 & 2022